Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Feb 24, 2025
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats:
Read more at globenewswire.com
